These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33011857)

  • 1. Methylglyoxal-Mediated Dopamine Depletion, Working Memory Deficit, and Depression-Like Behavior Are Prevented by a Dopamine/Noradrenaline Reuptake Inhibitor.
    de Almeida GRL; Szczepanik JC; Selhorst I; Schmitz AE; Dos Santos B; Cunha MP; Heinrich IA; de Paula GC; De Bem AF; Leal RB; Dafre AL
    Mol Neurobiol; 2021 Feb; 58(2):735-749. PubMed ID: 33011857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice.
    Szczepanik JC; de Almeida GRL; Cunha MP; Dafre AL
    Neurochem Res; 2020 Feb; 45(2):354-370. PubMed ID: 31786717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
    Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
    J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
    Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
    J Pharmacol Exp Ther; 2002 Dec; 303(3):952-8. PubMed ID: 12438514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP; Nielsen EØ; Hummel R; Redrobe JP; Mirza N; Weikop P
    Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.
    Schmitz AE; de Souza LF; Dos Santos B; Maher P; Lopes FM; Londero GF; Klamt F; Dafre AL
    Neurotox Res; 2017 Oct; 32(3):340-350. PubMed ID: 28478530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
    Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
    PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX; Perry KW; Wong DT
    Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.
    Schmeichel BE; Zemlan FP; Berridge CW
    Neuropharmacology; 2013 Jan; 64(1):321-8. PubMed ID: 22796428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test.
    Espejo EF; Miñano FJ
    Neuroscience; 1999 Jan; 88(2):609-15. PubMed ID: 10197779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of early life permethrin exposure on spatial working memory and on monoamine levels in different brain areas of pre-senescent rats.
    Nasuti C; Carloni M; Fedeli D; Gabbianelli R; Di Stefano A; Serafina CL; Silva I; Domingues V; Ciccocioppo R
    Toxicology; 2013 Jan; 303():162-8. PubMed ID: 23174539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression.
    Lu Q; Mouri A; Yang Y; Kunisawa K; Teshigawara T; Hirakawa M; Mori Y; Yamamoto Y; Libo Z; Nabeshima T; Saito K
    Behav Brain Res; 2019 Oct; 372():112053. PubMed ID: 31288060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel heterocyclic compound improves working memory in the radial arm maze and modulates the dopamine receptor D1R in frontal cortex of the Sprague-Dawley rat.
    Hussein AM; Aher YD; Kalaba P; Aher NY; Dragačević V; Radoman B; Ilić M; Leban J; Beryozkina T; Ahmed ABMA; Urban E; Langer T; Lubec G
    Behav Brain Res; 2017 Aug; 332():308-315. PubMed ID: 28629964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study.
    Kobayashi T; Hayashi E; Shimamura M; Kinoshita M; Murphy NP
    Psychopharmacology (Berl); 2008 May; 197(4):567-80. PubMed ID: 18274731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.